Lipoprotein (a): Knowns, unknowns and uncertainties

M Ruscica, CR Sirtori, A Corsini, GF Watts… - Pharmacological …, 2021 - Elsevier
Over the last 10 years, there have been advances on several aspects of lipoprotein (a)
which are reviewed in the present article. Since the standard immunoassays for measuring …

Lipoprotein (a): a genetically determined risk factor for Cardiovascular disease

SM Marcovina - Critical Reviews in Clinical Laboratory Sciences, 2023 - Taylor & Francis
Lipoprotein (a) is a complex lipoprotein with unique characteristics distinguishing it from all
the other apolipoprotein B-containing lipoprotein particles. Its lipid composition and the …

Lipoprotein (a) in health and disease

F Kronenberg, A Steinmetz, GM Kostner… - Critical reviews in …, 1996 - Taylor & Francis
Abstract Lipoprotein (a)[Lp (a)] represents an LDL-like particle to which the Lp (a)-specific
apolipoprotein (a) is linked via a disulfide bridge. It has gained considerable interest as a …

Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein (a) and Cardiovascular Disease: recent advances and future directions

SM Marcovina, ML Koschinsky, JJ Albers… - Clinical …, 2003 - academic.oup.com
It has been estimated that∼ 37% of the US population judged to be at high risk for
developing coronary artery disease (CAD), based on the National Cholesterol Education …

[HTML][HTML] Lipoprotein (a): biology and clinical importance

SPA McCormick - The Clinical Biochemist Reviews, 2004 - ncbi.nlm.nih.gov
Abstract Lipoprotein (a)[Lp (a)] is a unique lipoprotein that has emerged as an independent
risk factor for developing vascular disease. Plasma Lp (a) levels above the common cut-off …

[HTML][HTML] The long journey of lipoprotein (a) from cardiovascular curiosity to therapeutic target

ML Koschinsky, F Kronenberg - Atherosclerosis, 2022 - Elsevier
Atherosclerosis, as the official journal of the European Atherosclerosis Society (EAS),
decided that it would be timely to publish a comprehensive collection of review articles on …

[HTML][HTML] Lipoprotein (a) measurement issues: are we making a mountain out of a molehill?

F Kronenberg - Atherosclerosis, 2022 - Elsevier
Abstract Lipoprotein (a)[Lp (a)] became besides LDL cholesterol one of the most attractive
targets for intervention in cardiovascular disease. Strong genetic evidence supports the …

[PDF][PDF] Lipoprotein (a)

F Kronenberg - … and treatment of atherosclerosis: improving state …, 2021 - library.oapen.org
Abstract Lipoprotein (a)[Lp (a)] is an atherogenic lipoprotein with a strong genetic regulation.
Up to 90% of the concentrations are explained by a single gene, the LPA gene. The …

Lipoprotein (a): an emerging cardiovascular risk factor

G Lippi, G Guidi - Critical reviews in clinical laboratory sciences, 2003 - Taylor & Francis
Lipoprotein (a) is a cholesterol-enriched lipoprotein, consisting of a covalent linkage joining
the unique and highly polymorphic apolipoprotein (a) to apolipoprotein B100, the main …

Lipoprotein (a) and the atherothrombotic process: mechanistic insights and clinical implications

AM Scanu - Current atherosclerosis reports, 2003 - Springer
Although many epidemiologic studies have pointed at an association between plasma
levels of lipoprotein (a)(Lp (a)) and cardiovascular risk, the data obtained have been …